Nuveen Intermediate Duration Municipal Term Fund
Change company Symbol lookup
Select an option...
XNIDX Nuveen Intermediate Duration Municipal Term Fund
PSBQ PSB Holdings Inc
RONI Rice Acquisition Corp II
SUP Superior Industries International Inc
NECB Northeast Community Bancorp Inc
NIDB Northeast Indiana Bancorp Inc
SPXC SPX Technologies Inc
ULTA Ulta Beauty Inc
HTGM HTG Molecular Diagnostics Inc
MLEC Moolec Science SA

Closing Price
Day's Change
0.01 (0.07%)
B/A Size
Day's High
Day's Low

Alector to Participate in Upcoming Healthcare Conferences

4:05 pm ET March 1, 2023 (Globe Newswire) Print
Alector to Participate in Upcoming Healthcare ConferencesGlobeNewswireMarch 01, 2023

SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:

  • Cowen 43rd Annual Health Care Conference (Boston, Massachusetts)
    • Tuesday, March 7, 2023, at 10:30 a.m. ET, panel
  • Stifel 2023 CNS Days (Virtual)
    • Tuesday, March 28, 2023, at 12:00 p.m. ET, fireside chat

A webcast of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the Alector website at Replays of the Cowen and Stifel webcasts will be available on the Alector website for 30 and 90 days, respectively, following the presentation dates.

About Alector

Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain's immune system and enable rejuvenated immune cells to counteract emerging brain pathologies. Alector's immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer's disease. Alector is headquartered in South San Francisco, California. For additional information, please visit



Katie Hogan


1AB (media)

Dan Budwick


Argot Partners (investors)

Carrie McKim

Argot Partners


Primary Logo

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.